drugset / Trial / NCT01204086
Pharmacogenomics Studies of Antidepressants
Phase 4
Unknown
200 enrolled
National Cheng-Kung University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to establish the clinical effectiveness of antidepressants by pharmacogenomic approach, and to determine the levels of inflammatory factors between the baseline and the end point of the study in Taiwanese major depressive disorder (MDD) patients.
Timeline
- Start
- 2007-03
- Primary completion
- 2010-12
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluoxetine | Small molecule | 20 mg | — |
| Subject | Venlafaxine | Small molecule | 75 mg | — |